The Enantioselective-Controlled Delivery of Propranolol by Cellulose

Total Page:16

File Type:pdf, Size:1020Kb

The Enantioselective-Controlled Delivery of Propranolol by Cellulose The Enantioselective-Controlled Delivery of Propranolol by Cellulose Membrane Grafted with Molecularly Imprinted Polymer Chatchada Bodhibukkana A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Pharmaceutical Sciences Prince of Songkla University 2008 i Copyright of Prince of Songkla University Thesis Title The Enantioselective-Controlled Delivery of Propranolol by Cellulose Membrane Grafted with Molecularly Imprinted Polymer Author Miss Chatchada Bodhibukkana Major program Pharmaceutical Sciences Major Advisor Examining Committee ………………………………………… ………………………………Chairperson (Assoc. Prof. Dr. Roongnapa Srichana) (Assoc. Prof. Dr. Ruedeekorn Wiwattanapatapee) ………………………………Committee Co-advisor (Assoc. Prof. Dr. Varaporn Junyaprasert ) ………………………………………… ………………………………Committee (Assoc. Prof. Dr. Teerapol Srichana) (Assoc. Prof. Dr. Roongnapa Srichana) ………………………………………… ………………………………Committee (Prof. Gary P. Martin) (Assoc. Prof. Dr. Teerapol Srichana) The Graduate School, Prince of Songkla University, has approved this thesis as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Pharmaceutical Sciences …………………………………………… (Assoc. Prof. Dr. Krerkchai Thongnoo) Dean of Graduate School ii propranolol !" #$ %& '(")* %&% **+, - )!,!. */*- 0 1,!2 ( 2550 ! 26 7 %8%),(9-+:%&;*,< + (composite membrane) #$ ; :%%* %&% **+, (Molecularly imprinted polymer, MIP) *& !" L* %&L* ; ; S-enantiomer ; racemic propranolol + ,: N68 +%& +N$'O !,& %&$*- #$ ") ,: N!,8 * %&% **+, - +. silanisation %&$ *- ( #$ %&;,: N!,8 * %:) ; +P ( (% *& N" 9 +. * Q#!,& Q" #6&!,8 MIP %&%:) ; * ( S-propranolol ;9$ ,: N68 :* Q#!,& N) methacrylic acid ethylene glycol dimethacrylate #6&+P cross-linker % S- propranolol +P (,)** ,8 ( -" -(,)**;9$ , Q+N Q)"*% **+,%&L* ; ; ,8 #6&; 26 7 9 * %&L* S-propranolol + ") %& L* ; ; S-MIP membrane ,8 ) NV+P W ; #$ X ( %&!,8 * %&% **+,;+P (,)!) N" +- %+/1 * &68 N ; %8 L* 9*Q"! %) , & 26 7 ") propranolol prodrug #6& N"NX ) iii $+ ;,%(,) N$'O !,& prodrugs %:) :,V( ;; S-MIP membrane %& ; ;; ( -Q" %%&-& - ,8 %:) :" :6(,)**(" %&- ; %8 26 7 in vitro study ,8 S-MIP membrane 9 ++ L* S-propranolol ; racemic propranolol 26 7 W W)N ,N $ #6&W N"NX 962, 1 * +- #$ ; :%%* %&% **+, - N, !"+P W)N ,L* N, racemic propranolol ; %8W ,!%8 N"NX ) ++ S-MIP membrane +P ++ facilitate transport W Q [fixed carrier] & 26 7 ,'' #6&+O;;,( ^ (! pH ) %&%W( +` N) S-propranolol [fixed carrier] ; 9W ( ++ L* :) 9 S- MIP composite membraneQ" #6& ;; - (,)** ,8 ;$- ,'' pH 7.4 %&L* S-enantiomer ; racemic propranolol ;$ ) 0% racemic propranolol prodrugs %& propranolol prodrug Q 9*& *W " $W)N ,N $ Q" & 26 7 W poloxamer chitosan gel ( L* *) chitosan gel :) 9%&% +P (,) %& L* ; ; S-propranolol 0%& poloxamer gel #6&%:) N ) Q :) ( ( chitosan gel N" W %&$ (high flux) *" ,8%:) 9 L* S-propranolol W W)N ,N $ , ,8 chitosan gel ;69$ *& Q+ !"+P reservoir N, $W)N ,( Q+ enantiomer-controlled delivery patch ! reservoir (%68 chitosan gel %&% racemic propranolol HCl " Q+ N) S-MIP composite membrane laminated backing #6& transdermal patch %& (%68 ,8 9:) 9 S-propranolol % , :,V iv & +%&W)N ,N $ 26 7 (in vivo ) #6&: 1,!; 2 ( (Cmax , T max AUC 0-24 ) %&Q"; W + ,8 9%:%Q" , N" S- propranolol gel topical application ; W !%8 N"NX ) S-MIP composite membrane %2, 1 * N, Q+ !"+P %& L* ; ; W)N , racemic propranolol v Thesis Title The Enantioselective-Controlled Delivery of Propranolol by Cellulose Membrane Grafted with Molecularly Imprinted Polymer Author Miss Chatchada Bodhibukkana Major program Pharmaceutical Sciences Academic year 2007 ABSTRACT The aim of this thesis was to develop a composite membrane of bacterially- derived cellulose and molecularly imprinted polymer (MIP) for use as a transdermal enantioselective controlled-release system of racemic propranolol. The composite membranes were produced by the controlled pore functionalization of bacterial cellulose membranes using a molecularly imprinted polymer layer synthesis. The reactive pore-filling of an asymmetric porous cellulose membrane with a MIP thin- layer was modified using a silanised coupler as an additional anchor for the MIP. MIP thin-layers with specific binding sites for S-propranolol were synthesized by copolymerization of methacrylic acid with a cross-linker, ethylene glycol dimethacrylate in the presence of S-propranolol the template molecule and the latter was subsequently extracted. Selective transport of S-propranolol through the MIP composite membrane was obtained, although this was determined mostly by the parent cellulose membrane with some ancillary contributory effect from the MIP layer. vi In addition, an enantioselectivity in the transport of propranolol prodrug enantiomers was found, suggesting that the shape and functional groups orientation, which are similar to that of the print molecule were essential for enantiomeric recognition of the MIP composite membrane. The enantioselectivity of S-MIP membranes was also shown when the release of propranolol enantiomers was studied in vitro using rat skin, with racemic propranolol contained in the donor compartment. The results obtained, demonstrated the potential use of the composite membrane of bacterially-derived cellulose and molecularly imprinted polymer as a transdermal enantioselective controlled-release system of racemic propranolol. The result obtained from the in vitro release study showed that the selective release characteristic of the S-MIP membrane is the facilitated permeation via the ‘fixed-carrier’ mechanism such that the interaction between ‘fixed-carrier’ sites and S-propranolol can occur in aqueous buffers, and factors such as pH have been shown to have an influence. The template recognition of the S-MIP composite membrane was found to be highest in pH 7.4 buffer and the selective controlled delivery of the active S-enantiomer from racemic propranolol was greater than that from racemic propranolol prodrugs. In addition, the propranolol prodrug did not show the ability in increasing the penetration of the drug across the excised rat skin. Subsequently, the MIP thin-layer composited cellulose membrane with selectivity for S-propranolol was employed as the enantioselective-controlled release system. The effect of gel reservoir (poloxamer and chitosan) on enantioselective delivery was investigated. The chitosan gel allowed excellent selectivity for delivery of the S-propranolol enantiomer, whilst the more rheologically vii structured poloxamer gel formulation provided no selective release of S-propranolol. The chitosan gel exhibited high flux and had the ability to enantioselective deliver S- propranolol across excised rat skin. The reservoir patch for enantiomer-controlled delivery of propranolol was therefore fabricated by incorporating the chitosan gel formulation containing racemic propranolol hydrochloride into the MIP composite membrane laminated backing. These patch devices were shown to exhibit the significant stereoselectivity uptake of propranolol when attached to the skin, using pharmacokinetic studies in Wistar rats. S -Propranolol enantiomer plasma concentration profiles for the transdermal patch in the in vivo study were comparable to data for the gel formulations that were applied directly to skin, and containing a single S-enantiomer of propranolol. The results demonstrate that the transdermal patch based on the MIP composite membrane-controlled release system may have potential in the enantioselective-controlled delivery of the S-isomer of racemic propranolol. viii ACKNOWLEDGEMENTS I am especially grateful to my advisors Associate Professor Dr. Roongnapa Srichana and Associate Professor Dr. Teerapol Srichana for their advice and guidance throughout the course of this study. I express my sincere thanks to supervisors Professor Gary P. Martin, Professor Marc Brown and Dr. Stuart Jones for their suggestions and especially for their supports during my study in London. I would also like to thank Dr. Sanae Kaewnopparat and Miss Kiammarat Bauking for their assistance in cellulose membrane production, and Dr. Thanaporn Amnuaikit, Mr. Pisit Bauking and Mrs. Rachawan Limviwatkul for their assistance in technical work with animal experimentation. Financial support from the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0160/2545) is acknowledged Special thanks must go to my mother for her love and understanding, encouragement and supports and particularly for everything that she has done for me all of my life. Chatchada Bodhibukkana ix CONTENTS Page Contents x List of Tables xix List of Figures xxiii Chapters 1. Introduction 1.1. Literature reviews 1 1.1.1. Chirality 1 1.1.1.1. History of optical isomerism 1 1.1.1.2. Stereochemistry and biological activities 2 1.1.1.3. Classification of drug activity 5 1.1.1.3. Chiral separations 9 1.1.2. Transdermal drug delivery 13 1.1.2.1. Basic structure of the skin 13 1.1.2.2. Basic skin functions 21 1.1.2.3. Routes of absorption across the skin 22 1.1.2.4. Transdermal drug delivery system 25 1.1.3. Molecularly imprinted polymer 29 1.1.3.1. The concept of molecular imprinting 29 1.1.3.2. Configurations and applications of molecular imprinted 33 polymers 1.1.3.3. Molecularly imprinted membrane 34 x CONTENTS (continued) Page 1.2. Objectives of the thesis 40 1.2.1. Propranolol: the drug of
Recommended publications
  • Positive Allosteric Modulators (Pams) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2021 Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain Jayden Elmer Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Behavioral Neurobiology Commons, Behavior and Behavior Mechanisms Commons, Medicinal and Pharmaceutical Chemistry Commons, Nervous System Diseases Commons, and the Pharmacology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/6777 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. 2021 Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects and Neuropathic Pain Jayden A. Elmer Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects and Neuropathic Pain A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University By Jayden Aric Elmer Bachelor of Science, University of Virginia, 2018 Director: Dr. Aron Lichtman, Professor, Department of Pharmacology & Toxicology; Associate Dean of Research and Graduate Studies, School of Pharmacy Virginia Commonwealth University Richmond, Virginia July 2021 Acknowledgements I would first like to extend my gratitude towards the CERT program at VCU. The CERT program opened the doors for me to get involved in graduate research.
    [Show full text]
  • Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected]
    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 4-25-2018 Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected] DOI: 10.25148/etd.FIDC006565 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Chemistry Commons Recommended Citation Seither, Joshua Zolton, "Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances" (2018). FIU Electronic Theses and Dissertations. 3823. https://digitalcommons.fiu.edu/etd/3823 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida APPLICATION OF HIGH RESOLUTION MASS SPECTROMETRY FOR THE SCREENING AND CONFIRMATION OF NOVEL PSYCHOACTIVE SUBSTANCES A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in CHEMISTRY by Joshua Zolton Seither 2018 To: Dean Michael R. Heithaus College of Arts, Sciences and Education This dissertation, written by Joshua Zolton Seither, and entitled Application of High- Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this dissertation and recommend that it be approved. _______________________________________ Piero Gardinali _______________________________________ Bruce McCord _______________________________________ DeEtta Mills _______________________________________ Stanislaw Wnuk _______________________________________ Anthony DeCaprio, Major Professor Date of Defense: April 25, 2018 The dissertation of Joshua Zolton Seither is approved.
    [Show full text]
  • The Newest Cathinone Derivatives As Designer Drugs: an Analytical and Toxicological Review
    Forensic Toxicol DOI 10.1007/s11419-017-0385-6 REVIEW ARTICLE The newest cathinone derivatives as designer drugs: an analytical and toxicological review 1,3 3 2 1 Milena Majchrzak • Rafał Celin´ski • Piotr Kus´ • Teresa Kowalska • Mieczysław Sajewicz1 Received: 30 July 2017 / Accepted: 22 August 2017 Ó The Author(s) 2017. This article is an open access publication Abstract Conclusions To our knowledge, this is the most current Purpose Currently, among new psychoactive substances, review presenting new synthetic cathinones. Political cathinone derivatives constitute the biggest group, which authorities should take measures to implement and enforce are mainly classified into N-alkylated, 3,4-methylenedioxy- generic scheduling (comprehensive system) laws to control N-alkylated, N-pyrrolidinyl, and 3,4-methylenedioxy-N- the diversely modified synthetic cathinones. Supplement- pyrrolidinyl derivatives. These derivatives are actively ing the existing databases with new findings can greatly being subjected to minor modifications at the alkyl chains facilitate the efforts of forensic toxicologists. or the aromatic ring to create new synthetic cathinones with the goal of circumventing laws. In this review, the new Keywords New synthetic cathinones Á Designer drugs Á synthetic cathinones that have appeared on the illegal drug NPS Á LC–MS Á GC–MS Á NMR market during the period 2014–2017 are highlighted, and their characterization by gas chromatography–mass spec- trometry and liquid chromatography–tandem mass spec- Introduction trometry is presented. Methods Various key words were used to conduct an Cathinone is one of the biologically active alkaloids found extensive literature search across a number of databases, in the khat shrub (Catha edulis).
    [Show full text]
  • New Psychoactive Substances (NPS)
    New Psychoactive Substances (NPS) LGC Quality Reference ISO 9001 ISO/IEC 17025 ISO Guide 34 materials GMP/GLP ISO 13485 2019 ISO/IEC 17043 Science for a safer world LGC offers the most extensive and up-to-date range of New LGC is a global leader in Psychoactive Substances (NPS) measurement standards, reference materials. reference materials, laboratory services and proficiency testing. With 2,600 professionals working When you make a decision using The challenge The LGC response We are the UK’s in 21 countries, our analytical our resources, you can be sure it’s designated National measurement and quality control based on precise, robust data. And New Psychoactive Substances In response to the ever-expanding LGC Standards provides the widest Measurement services are second-to-none. together, we’re creating fairer, safer, (NPS) continue to be identified, range of NPS being developed, LGC range of reference materials Institute for chemical more confident societies worldwide. and it appears that moves by the has produced a comprehensive available from any single supplier. and bioanalytical As a global leader, we provide the United Nations and by individual range of reference materials that We work closely with leading widest range of reference materials lgcstandards.com countries to control lists of meet the rapidly changing demands manufacturers to provide improved measurement. available from any single supplier. named NPS may be encouraging of the NPS landscape. Many of access to reference materials, the development of yet further these products are produced under with an increasingly large range variants to avoid these controls. the rigorous quality assurance of parameters, for laboratories standards set out in ISO Guide 34.
    [Show full text]
  • Chiral Capillary Electrophoresis-Mass Spectrometry: Developments and Applications of Novel Glucopyranosdie Molecular Micelles Yijin Liu Georgia State University
    Georgia State University ScholarWorks @ Georgia State University Chemistry Dissertations Department of Chemistry Spring 5-9-2016 Chiral capillary electrophoresis-mass spectrometry: developments and applications of novel glucopyranosdie molecular micelles yijin liu Georgia State University Follow this and additional works at: https://scholarworks.gsu.edu/chemistry_diss Recommended Citation liu, yijin, "Chiral capillary electrophoresis-mass spectrometry: developments and applications of novel glucopyranosdie molecular micelles." Dissertation, Georgia State University, 2016. https://scholarworks.gsu.edu/chemistry_diss/120 This Dissertation is brought to you for free and open access by the Department of Chemistry at ScholarWorks @ Georgia State University. It has been accepted for inclusion in Chemistry Dissertations by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact [email protected]. CHIRAL CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRY: DEVELOPMENTS AND APPLICATIONS OF NOVEL GLUCOPYRANOSIDE MOLECULAR MICELLES by YIJIN LIU Under the Direction of Dr. Shahab A. Shamsi by YIJIN LIU Under the Direction of Dr. Shahab A. Shamsi ABSTRACT Micellar electrokinetic chromatography (MEKC), one of the major capillary electrophoresis (CE) modes, has been interfaced to mass spectrometry (MS) to provide high sensitivity and selectivity for analysis of chiral compounds. The research in this dissertation presents the development of novel polymeric glucopyranoside based molecular micelles (MoMs) (aka. polymeric surfactants) and their application in chiral MEKC-MS. Chapter 1 is a review of chiral CE-MS - in the period 2010-2015. In this chapter, the fundamental of chiral CE and CE-MS is illustrated and the recent developments of chiral selectors and their applications in chiral EKC-MS, CEC-MS and MEKC-MS are discussed in details.
    [Show full text]
  • Products Issue 3 | 2020 Toxicology New Product Listing
    NEW PRODUCTS ISSUE 3 | 2020 TOXICOLOGY NEW PRODUCT LISTING NEW PRODUCT LISTING Issue No. ISSUE3 3 Toxicology Chiron Cat. No. Name (Synonym) CAS No. Antibiotics 13330.37 Erythromycin A dihydrate 59319-72-1 14289.7 Ipronidazole 14885-29-1 14290.17 Pirlimycin hydrochloride 78822-40-9 14292.13 Succinylsulfathiazole (Succinylsulphathiazole, Sulfasuccidine, Sulfasuxidine) 116-43-8 14293.11 Sulfamoxole (Sulfamoxol, Sulphamoxole, Sulfamoxolum, Sulfanilamide) 729-99-7 14294.8 Tinidazole (Tinidazol, Timidazole, Tindamax) 19387-91-8 Antidepressants 10356.19 Clomipramine-d6 hydrochloride (N,N-dimethyl-d6) 1189882-28-7 11899.25 Nefazodone hydrochloride 82752-99-6 Antiparasitic drugs 14270.12 Aprinocid (Arpocox) 55779-18-5 14291.6 Roxarsone 121-19-7 14501.31 Fenpicoxamid 517875-34-2 15292.12 GS 441524 (Active metabolite of Remdesivir) 1191237-69-0 14035.5 Hydroxydimetridazole (HMMNI) 936-05-0 Cannabinoids (Synthetic) 14283.19 5F-ABICA N-(4-hydroxypentyl) metabolite (4OH-5F-ABICA, 4OH-5F-AMBICA) N/A 14280.23 5F-CUMYL-PICA N-(4-hydroxypentyl) metabolite (4OH-5F-Cumyl-PICA) N/A 14281.21 5-Fluoro-SDB-006 N-(4-hydroxypentyl) metabolite (4OH-5F-SDB-006) N/A 14285.20 5F-MDMB-PICA metabolite 4 (4OH-5F-MDMB-PICA-acid, SCM090) N/A 14284.21 5F-MDMB-PICA N-(4-hydroxypentyl) metabolite (4OH-5F-MDMB-PICA) N/A 14286.19 5F-MMB-PICA N-(4-hydroxypentyl), 3-methylbutanoic acid metabolite (>80%) N/A 14287.23 5F-PB-22 N-(4-hydroxypentyl) metabolite (4OH-5F-PB-22) N/A 14279.23 5F-SGT-161 N-(4-hydroxypentyl) metabolite (4OH-5F-SGT-161) N/A 14443.26 AM-1220 (AM1220) 137642-54-7
    [Show full text]
  • In Vitro Characterization of New Psychoactive Substances at The
    Forensic Science International 317 (2020) 110553 Contents lists available at ScienceDirect Forensic Science International journal homepage: www.elsevier.com/locate/forsciint In vitro characterization of new psychoactive substances at the m-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects a,1 a,b,1 a,b a,b,2 Anna Åstrand , Davide Guerrieri , Svante Vikingsson , Robert Kronstrand , a,b, ,2 Henrik Green * a Division of Drug Research, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, SE 581 85, Linköping, Sweden b Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, SE, 587 58 Linköping, Sweden A R T I C L E I N F O A B S T R A C T Article history: New psychoactive substances (NPS) appear on the recreational market on a monthly basis, with unclear Received 23 March 2020 toxicology, resulting in an increasing number of fatalities. Identification of drug targets and potencies is Received in revised form 15 October 2020 crucial for understanding and treating intoxications and for scheduling processes. In this study 60 NPS Accepted 17 October 2020 and metabolites belonging to opioids, cannabinoids and serotonergic hallucinogens classes were Available online 23 October 2020 screened for in vitro activation of the m-opioid, CB1, 5-HT1A and 5-HT2A receptors using the AequoZen cell system. Fentanyl and NBOMe analogues were chosen for full dose-response characterization of the Keywords: m-opioid and 5-HT2A receptors, respectively. m-Opioid receptor agonists Most substances activated their corresponding target receptor.
    [Show full text]
  • International Consensus Standards for Commercial Diving and Underwater Operations 2.4
    International Consensus Standards For Commercial Diving And Underwater Operations 2.4 2.4.2 ADCI PHYSICAL EXAMINATION STANDARDS Patient history is recorded on pages 2-15 through 2-16 of the form set. Pages 2-17 and 2-18 are used to record specific findings during the conduct of the examination. The following headings refer to and explain the numbered boxes on the ADCI physical examination form on pages 2-17 and 2-18. A sample copy of these forms is enclosed in this standard. Use of these forms ensures quality and consistency throughout the commercial diving industry. These forms may be obtained from the ADCI website. 1 Name Record. Social Security Number Record. 2 or Passport Number 3 Height No set limits. The weight limits listed in the maximum allowable weight chart (2.4.9) should apply. If a diver exceeds these limits and the cognizant physician feels the increase is due to muscular build and physical fitness, a variance may be appropriate. A variance may be appropriate for divers who do not meet 4 Weight the weight limits but are at 23% body fat or less as measured by impedance or hydrostatic fat testing. Furthermore, individuals who fall within these weight limits but who present an excess of fatty tissue should be disqualified. 5 Body Fat Optional. According to US Navy, 23% for males, 34% for females. 6 Body Mass Index (BMI) Optional. Calculation for BMI = (weight in pounds x 703) height in inches2. The maximum BMI allowable according to the U.S. Navy height and weight table is 28.
    [Show full text]
  • Structure-Function Analysis of the Dopamine Transporter in the Presence of Synthetic Cathinones and Amphetamines Shari Melissa Radford
    Purdue University Purdue e-Pubs Open Access Theses Theses and Dissertations 12-2016 Structure-function analysis of the dopamine transporter in the presence of synthetic cathinones and amphetamines Shari Melissa Radford Follow this and additional works at: https://docs.lib.purdue.edu/open_access_theses Recommended Citation Radford, Shari Melissa, "Structure-function analysis of the dopamine transporter in the presence of synthetic cathinones and amphetamines" (2016). Open Access Theses. 887. https://docs.lib.purdue.edu/open_access_theses/887 This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact [email protected] for additional information. Graduate School Form 30 Updated PURDUE UNIVERSITY GRADUATE SCHOOL Thesis/Dissertation Acceptance This is to certify that the thesis/dissertation prepared By Shari Radford Entitled Structure-function analysis of the dopamine transporter in the presence of synthetic cathinones and amphetamines For the degree of Master of Science Is approved by the final examining committee: Eric L. Barker Chair Markus A. Lill Nicholas Noinaj Richard M. Van Rijn To the best of my knowledge and as understood by the student in the Thesis/Dissertation Agreement, Publication Delay, and Certification Disclaimer (Graduate School Form 32), this thesis/dissertation adheres to the provisions of Purdue University’s “Policy of Integrity in Research” and the use of copyright material. Approved by Major Professor(s): Eric L. Barker Approved by: Jean-Christophe Rochet 12/2/2016 Head of the Departmental Graduate Program Date STRUCTURE-FUNCTION ANALYSIS OF THE DOPAMINE TRANSPORTER IN THE PRESENCE OF SYNTHETIC CATHINONES AND AMPHETAMINES A Dissertation Submitted to the Faculty of Purdue University by Shari Melissa Radford In Partial Fulfillment of the Requirements for the Degree of Master of Science December 2016 Purdue University West Lafayette, Indiana ii ACKNOWLEDGMENTS I would like to acknowledge my primary mentor Dr.
    [Show full text]
  • Overview of the Major Classes of New Psychoactive Substances
    Open Chemistry 2021; 19: 60–106 Review Article Vera Lukić,Ružica Micić, Biljana Arsić*, Bojan Nedović, Živana Radosavljević Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs https://doi.org/10.1515/chem-2021-0196 received May 26, 2020; accepted August 20, 2020 Abbreviations Abstract: Themisuseofpsychoactivesubstancesis NMR nuclear magnetic resonance attracting a great deal of attention from the general public. MS mass spectrometry An increase use of psychoactive substances is observed NPS new psychoactive substances among young people who do not have enough awareness USA United States of America of the harmful effects of these substances. Easy access to GABA γ-aminobutyric acid illicit drugs at low cost and lack of effective means of rou- EU European Union tine screening for new psychoactive substances (NPS) LSD lysergic acid diethylamide have contributed to the rapid increase in their use. New LSA lysergamide research and evidence suggest that drug use can cause a UK United Kingdom variety of adverse psychological and physiological effects DMT N,N-dimethyltryptamine on human health (anxiety, panic, paranoia, psychosis, NE norepinephrine and seizures). We describe different classes of these NPS 5-HT 5-hydroxytryptamine drugs with emphasis on the methods used to identify them ENT ears, nose and throat and the identification of their metabolites in biological IV intravenous specimens. This is the first review that thoroughly gives GC-MS gas chromatography-mass spectrometry the literature on both natural and synthetic illegal drugs IR infra-red with old known data and very hot new topics and investi- CNS central nervous system gations, which enables the researcher to use it as a starting MEA microelectrode arrays point in the literature exploration and planning of the own hDAT human dopamine reuptake transporter research.
    [Show full text]
  • Monitoring New Psychoactive Substances Use Through Wastewater Analysis: Current Situation, 2 Challenges and Limitations
    1 Monitoring New Psychoactive Substances use through wastewater analysis: current situation, 2 challenges and limitations 3 4 L. Bijlsma#, A. Celma#, F.J. López, F. Hernández* 5 6 Research Institute for Pesticides and Water, University Jaume I, Castellón, Spain 7 8 # Co-first authors 9 *Corresponding author: 10 Félix Hernández, Research Institute for Pesticides and Water, University Jaume I, 12080 Castellón, 11 Spain. E-mail address: [email protected] 12 13 14 Abstract 15 New Psychoactive Substances (NPS) are compounds that produce similar effects to those induced by 16 illicit drugs (ID), such as cocaine, cannabis and amphetamines, but are not strictly regulated by 17 international conventions. The consumption of NPS is a growing public health problem in many 18 communities. However, there is little knowledge regarding the extent and actual use of these new 19 substances. Monitoring NPS use is arduous and, therefore, different sources of information need to 20 be used to get more insight of the prevalence and diffusion of NPS use. Analysis of pooled urine (PU) 21 and wastewater (WW) shows strong potential, giving a different and complementary light on this 22 issue, although presents some limitations and challenges that must be taken into account. Liquid 23 Chromatography coupled to High Resolution Mass Spectrometry (LC-HRMS) is one of the most 24 powerful approaches for screening a large number of NPS because of the accurate-mass full-spectrum 25 acquisition measurements. By using a comprehensive and updated NPS database, LC-HRMS is flexible 26 enough to confront the ever-changing NPS market. In this “current opinion”, we give our point of view 27 on the usefulness of PU and WW analysis, and on the potential application of wastewater-based 28 epidemiology as source of information for NPS use, explaining the main bottlenecks and future 29 perspectives in this emerging research field.
    [Show full text]
  • Substance Abuse in the Workplaces of Our Bodies and Mind
    “Turn on, Tune in, Drop out “ Substance Abuse in the Workplaces of our bodies and mind.. Warren Silverman MD Brief History of Drug abuse – Mary Jane 1629 – Marijuana introduced to the Puritan colonies of New England 1765 – George Washington was cultivating Marijuana for a sore tooth 1800’s Tincture of Cannabis is available from pharmacies, unpopular due to variations in potency and dosage, but recreational use continues with Hashish clubs in most cities by 1885 By the 20th century, marijuana use was associated with racial groups and drug abusers and lost popularity The foreign origin of marijuana lead to propaganda against its use (as we have just seen), by 1930’s marijuana was considered wicked In the 1960’s, drug use was considered a demonstration of anti-establishment leanings and became popular Marijuana has remained a constant presence in our society with gradual legislation to decriminalize and legitimize its use Brief History of Drug Abuse - Opiates In colonial America, Opiate medications were common in London and imported to the colonies – used to treat pain from diarrhea, colds, fever, tooth aches, cholera, rheumatism, pelvic disorders, athlete’s foot and baldness 1784 Dr. William Buchan’s book tells people how to make their own tincture of Opium (paregoric) to keep around the house 1804 catalogue listed 90 brands of elixir, by 1905 it was more than 28,000 1803 Morphine developed (Morpheus – god of dreams) Hypodermic needle invented and by the civil war Morphine was widely used as injectable 1898 Heroin developed
    [Show full text]